Trial Profile
Phase II Study Evaluating Efficacy and Safety of Everolimus with Letrozole for Management of Advanced (unresectable or metastatic) Non Small Cell Lung Cancer (NSCLC) after Failure of Platinum-Based Treatment
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Letrozole (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Jul 2015 New trial record